Form 8-K - Current report:
SEC Accession No. 0001193125-24-273921
Filing Date
2024-12-10
Accepted
2024-12-10 06:32:29
Documents
17
Period of Report
2024-12-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d899097d8k.htm   iXBRL 8-K 35246
2 EX-4.1 d899097dex41.htm EX-4.1 73523
3 EX-4.2 d899097dex42.htm EX-4.2 65342
4 EX-10.1 d899097dex101.htm EX-10.1 374883
5 EX-99.1 d899097dex991.htm EX-99.1 8296
  Complete submission text file 0001193125-24-273921.txt   834109

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA maia-20241209.xsd EX-101.SCH 2852
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE maia-20241209_lab.xml EX-101.LAB 18739
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE maia-20241209_pre.xml EX-101.PRE 11709
19 EXTRACTED XBRL INSTANCE DOCUMENT d899097d8k_htm.xml XML 3744
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 241537098
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)